富时中国A50指数期货涨超1%。

Bank of Korea Governor Shin apologized at a National Assembly Finance and Economy Committee oversight hearing on the 12th for failing to adequately warn the public about risks from single-stock leveraged ETFs. He said that at end‑May he did not fully grasp volatility in the domestic equity market, particularly in the memory‑chip sector, and acknowledged the Bank’s June Financial Stability Report assessment—that single‑stock leveraged ETFs could prevent domestic capital outflows and help attract foreign inflows—was mistaken and inappropriate given the circumstances.

On Oct 12 Jindike shares hit the daily limit down after reports the stock could face a delisting-risk warning. The company’s board secretary office said it has timely disclosed required information to the CSRC and Shanghai Stock Exchange and has no other undisclosed material information. Jindike said its trivalent influenza vaccine has entered secondary packaging; commercial sales timing will depend on batch-release progress. On whether the quadrivalent vaccine is being paused temporarily or discontinued, the company said WHO issues H2 Northern Hemisphere influenza guidance early each year and China CDC issues vaccination guidance in July–August, and decisions will be made based on that year’s situation.